Interestingly, SphK1 and SphK2 appear to have opposite effects in cancer: SphK1 is considered pro-oncogenic in breast cancers [2], while SphK2 was shown to facilitate antiproliferative signaling [6]. This evidence concerns the gene SPHK2 and breast carcinoma.